China Bio-pharma Market Research Report 2017

December 2017 | 109 pages | ID: C34778561D4EN
QYResearch

Abstracts

The global Bio-pharma market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Bio-pharma development status and future trend in China, focuses on top players in China, also splits Bio-pharma by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Pfizer
• F. Hoffmann-La Roche AG
• Johnson & Johnson Services
• Sanofi, Amgen
• AbbVie
• Merck & Co., Inc
• Biogen Idec
• Bayer AG
• Eli Lilly and Company
• Novartis AG GlaxoSmithKline Plc
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Abbott Laboratories

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Monoclonal Antibodies
• Recombinant Proteins
• Granulocyte-Colony Stimulating Factor (G-CSF)
• Interferons
• Recombinant Human Insulin
• Erythropoietin
• Vaccines
• Growth Hormones
• Purified Proteins
• Others

On the basis of the end users/application, this report covers

• Metabolic Disorders
• Oncology
• Neurological Disorders
• Cardiovascular Diseases
• Inflammatory and Infectious Diseases
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Bio-pharma Market Research Report 2017

1 BIO-PHARMA OVERVIEW

1.1 Product Overview and Scope of Bio-pharma
1.2 Classification of Bio-pharma by Product Category
  1.2.1 China Bio-pharma Sales (K Pcs) Comparison by Type (2012-2022)
  1.2.2 China Bio-pharma Sales (K Pcs) Market Share by Type in 2016
  1.2.3 Monoclonal Antibodies
  1.2.4 Recombinant Proteins
  1.2.5 Granulocyte-Colony Stimulating Factor (G-CSF)
  1.2.6 Interferons
  1.2.7 Recombinant Human Insulin
  1.2.8 Erythropoietin
  1.2.9 Vaccines
  1.2.10 Growth Hormones
  1.2.11 Purified Proteins
  1.2.12 Others
1.3 China Bio-pharma Market by Application/End Users
  1.3.1 China Bio-pharma Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Metabolic Disorders
  1.3.3 Oncology
  1.3.4 Neurological Disorders
  1.3.5 Cardiovascular Diseases
  1.3.6 Inflammatory and Infectious Diseases
  1.3.7 Others
1.4 China Bio-pharma Market by Region
  1.4.1 China Bio-pharma Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Bio-pharma Status and Prospect (2012-2022)
  1.4.3 East China Bio-pharma Status and Prospect (2012-2022)
  1.4.4 Southwest China Bio-pharma Status and Prospect (2012-2022)
  1.4.5 Northeast China Bio-pharma Status and Prospect (2012-2022)
  1.4.6 North China Bio-pharma Status and Prospect (2012-2022)
  1.4.7 Central China Bio-pharma Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Bio-pharma (2012-2022)
  1.5.1 China Bio-pharma Sales (K Pcs) and Growth Rate (%)(2012-2022)
  1.5.2 China Bio-pharma Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA BIO-PHARMA MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Bio-pharma Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Bio-pharma Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Bio-pharma Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
2.4 China Bio-pharma Market Competitive Situation and Trends
  2.4.1 China Bio-pharma Market Concentration Rate
  2.4.2 China Bio-pharma Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Bio-pharma Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA BIO-PHARMA SALES AND REVENUE BY REGION (2012-2017)

3.1 China Bio-pharma Sales (K Pcs) and Market Share by Region (2012-2017)
3.2 China Bio-pharma Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Bio-pharma Price (USD/Pcs) by Regions (2012-2017)

4 CHINA '&B1&' SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)'

4.1 China Bio-pharma Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)
4.2 China Bio-pharma Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Bio-pharma Price (USD/Pcs) by Type (2012-2017)
4.4 China Bio-pharma Sales Growth Rate (%) by Type (2012-2017)

5 CHINA '&B1&' SALES BY APPLICATION (2012-2017)'

5.1 China Bio-pharma Sales (K Pcs) and Market Share by Application (2012-2017)
5.2 China Bio-pharma Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA BIO-PHARMA PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Bio-pharma Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche AG
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Bio-pharma Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson Services
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Bio-pharma Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi, Amgen
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Bio-pharma Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 AbbVie
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Bio-pharma Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 AbbVie Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Merck & Co., Inc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Bio-pharma Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Biogen Idec
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Bio-pharma Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Biogen Idec Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bayer AG
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Bio-pharma Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bayer AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Eli Lilly and Company
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Bio-pharma Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Novartis AG GlaxoSmithKline Plc
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Bio-pharma Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Bristol-Myers Squibb Company
6.12 AstraZeneca PLC
6.13 Abbott Laboratories

7 BIO-PHARMA MANUFACTURING COST ANALYSIS

7.1 Bio-pharma Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Bio-pharma

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Bio-pharma Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Bio-pharma Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA BIO-PHARMA MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Bio-pharma Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.2 China Bio-pharma Sales (K Pcs) Forecast by Type (2017-2022)
11.3 China Bio-pharma Sales (K Pcs) Forecast by Application (2017-2022)
11.4 China Bio-pharma Sales (K Pcs) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Bio-pharma Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Bio-pharma Sales (K Pcs) by Application (2016-2022)
Figure Product Picture of Bio-pharma
Table China Bio-pharma Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Bio-pharma Sales Volume Market Share by Types in 2016
Figure Monoclonal Antibodies Product Picture
Figure Recombinant Proteins Product Picture
Figure Granulocyte-Colony Stimulating Factor (G-CSF) Product Picture
Figure Interferons Product Picture
Figure Recombinant Human Insulin Product Picture
Figure Erythropoietin Product Picture
Figure Vaccines Product Picture
Figure Growth Hormones Product Picture
Figure Purified Proteins Product Picture
Figure Others Product Picture
Figure China Bio-pharma Sales (K Pcs) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Bio-pharma by Application in 2016
Figure Metabolic Disorders Examples
Table Key Downstream Customer in Metabolic Disorders
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Neurological Disorders Examples
Table Key Downstream Customer in Neurological Disorders
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Inflammatory and Infectious Diseases Examples
Table Key Downstream Customer in Inflammatory and Infectious Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Bio-pharma Sales (K Pcs) and Growth Rate (%)(2012-2022)
Figure China Bio-pharma Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Bio-pharma Sales of Key Players/Manufacturers (2012-2017)
Table China Bio-pharma Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Bio-pharma Sales Share (%) by Players/Manufacturers
Figure 2017 China Bio-pharma Sales Share (%) by Players/Manufacturers
Table China Bio-pharma Revenue by Players/Manufacturers (2012-2017)
Table China Bio-pharma Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Bio-pharma Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Bio-pharma Revenue Market Share (%) by Players/Manufacturers
Table China Market Bio-pharma Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Bio-pharma Average Price of Key Players/Manufacturers in 2016
Figure China Bio-pharma Market Share of Top 3 Players/Manufacturers
Figure China Bio-pharma Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Bio-pharma Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Bio-pharma Product Category
Table China Bio-pharma Sales (K Pcs) by Regions (2012-2017)
Table China Bio-pharma Sales Share (%) by Regions (2012-2017)
Figure China Bio-pharma Sales Share (%) by Regions (2012-2017)
Figure China Bio-pharma Sales Market Share (%) by Regions in 2016
Table China Bio-pharma Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Bio-pharma Revenue Market Share (%) by Regions (2012-2017)
Figure China Bio-pharma Revenue Market Share (%) by Regions (2012-2017)
Figure China Bio-pharma Revenue Market Share (%) by Regions in 2016
Table China Bio-pharma Price (USD/Pcs) by Regions (2012-2017)
Table China Bio-pharma Sales (K Pcs) by Type (2012-2017)
Table China Bio-pharma Sales Share (%) by Type (2012-2017)
Figure China Bio-pharma Sales Share (%) by Type (2012-2017)
Figure China Bio-pharma Sales Market Share (%) by Type in 2016
Table China Bio-pharma Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Bio-pharma Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Bio-pharma by Type (2012-2017)
Figure Revenue Market Share of Bio-pharma by Type in 2016
Table China Bio-pharma Price (USD/Pcs) by Types (2012-2017)
Figure China Bio-pharma Sales Growth Rate (%) by Type (2012-2017)
Table China Bio-pharma Sales (K Pcs) by Applications (2012-2017)
Table China Bio-pharma Sales Market Share (%) by Applications (2012-2017)
Figure China Bio-pharma Sales Market Share (%) by Application (2012-2017)
Figure China Bio-pharma Sales Market Share (%) by Application in 2016
Table China Bio-pharma Sales Growth Rate (%) by Application (2012-2017)
Figure China Bio-pharma Sales Growth Rate (%) by Application (2012-2017)
Table Pfizer Bio-pharma Basic Information List
Table Pfizer Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Pfizer Bio-pharma Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Pfizer Bio-pharma Sales Market Share (%) in China (2012-2017)
Figure Pfizer Bio-pharma Revenue Market Share (%) in China (2012-2017)
Table F. Hoffmann-La Roche AG Bio-pharma Basic Information List
Table F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure F. Hoffmann-La Roche AG Bio-pharma Sales Market Share (%) in China (2012-2017)
Figure F. Hoffmann-La Roche AG Bio-pharma Revenue Market Share (%) in China (2012-2017)
Table Johnson & Johnson Services Bio-pharma Basic Information List
Table Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Johnson & Johnson Services Bio-pharma Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Johnson & Johnson Services Bio-pharma Sales Market Share (%) in China (2012-2017)
Figure Johnson & Johnson Services Bio-pharma Revenue Market Share (%) in China (2012-2017)
Table Sanofi, Amgen Bio-pharma Basic Information List
Table Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Sanofi, Amgen Bio-pharma Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Sanofi, Amgen Bio-pharma Sales Market Share (%) in China (2012-2017)
Figure Sanofi, Amgen Bio-pharma Revenue Market Share (%) in China (2012-2017)
Table AbbVie Bio-pharma Basic Information List
Table AbbVie Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure AbbVie Bio-pharma Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure AbbVie Bio-pharma Sales Market Share (%) in China (2012-2017)
Figure AbbVie Bio-pharma Revenue Market Share (%) in China (2012-2017)
Table Merck & Co., Inc Bio-pharma Basic Information List
Table Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Merck & Co., Inc Bio-pharma Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Merck & Co., Inc Bio-pharma Sales Market Share (%) in China (2012-2017)
Figure Merck & Co., Inc Bio-pharma Revenue Market Share (%) in China (2012-2017)
Table Biogen Idec Bio-pharma Basic Information List
Table Biogen Idec Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Biogen Idec Bio-pharma Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Biogen Idec Bio-pharma Sales Market Share (%) in China (2012-2017)
Figure Biogen Idec Bio-pharma Revenue Market Share (%) in China (2012-2017)
Table Bayer AG Bio-pharma Basic Information List
Table Bayer AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Bayer AG Bio-pharma Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Bayer AG Bio-pharma Sales Market Share (%) in China (2012-2017)
Figure Bayer AG Bio-pharma Revenue Market Share (%) in China (2012-2017)
Table Eli Lilly and Company Bio-pharma Basic Information List
Table Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Eli Lilly and Company Bio-pharma Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Eli Lilly and Company Bio-pharma Sales Market Share (%) in China (2012-2017)
Figure Eli Lilly and Company Bio-pharma Revenue Market Share (%) in China (2012-2017)
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Basic Information List
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Sales Market Share (%) in China (2012-2017)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Revenue Market Share (%) in China (2012-2017)
Table Bristol-Myers Squibb Company Bio-pharma Basic Information List
Table AstraZeneca PLC Bio-pharma Basic Information List
Table Abbott Laboratories Bio-pharma Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bio-pharma
Figure Manufacturing Process Analysis of Bio-pharma
Figure Bio-pharma Industrial Chain Analysis
Table Raw Materials Sources of Bio-pharma Major Players/Manufacturers in 2016
Table Major Buyers of Bio-pharma
Table Distributors/Traders List
Figure China Bio-pharma Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure China Bio-pharma Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Bio-pharma Price (USD/Pcs) Trend Forecast (2017-2022)
Table China Bio-pharma Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Bio-pharma Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Bio-pharma Sales Volume Market Share Forecast by Type in 2022
Table China Bio-pharma Sales (K Pcs) Forecast by Application (2017-2022)
Figure China Bio-pharma Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Bio-pharma Sales Volume Market Share Forecast by Application in 2022
Table China Bio-pharma Sales (K Pcs) Forecast by Regions (2017-2022)
Table China Bio-pharma Sales Volume Share Forecast by Regions (2017-2022)
Figure China Bio-pharma Sales Volume Share Forecast by Regions (2017-2022)
Figure China Bio-pharma Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources